SVA

Symbol	last price	date	time	change	open	high	low	volume	P/E (ttm)	P/E (Forward)
SVA	3.57	9/2/2010	3:01pm	-0.17	3.71	3.71	3.50	376817

Summary

Sinovac Biotech, Ltd., a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of vaccines for human infectious diseases in the People's Republic of China. Its products include Healive, a vaccine for hepatitis A; Bilive, a combined hepatitis A and B vaccine; and Anflu, a split flu vaccine. The company also develops vaccines for the SARS virus, the H5N1 strain of pandemic influenza virus, and the Japanese encephalitis virus. Sinovac Biotech markets and sells its vaccine products primarily through various provincial and municipal centers for disease control and prevention. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China.